Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: technetx who wrote (88)	7/7/1998 7:22:00 AM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

Buy, Sell or Hold Recommendation Mason, Jim & Technetx, I believe that previous coverage was initiated by both Olde Discount Brokerage and Sterne, Agee, Leach from Atlanta , Ga. My bet is that they both will pick up where they left off and reiterate their buy recommendations. Others will follow suite within the next three months. This is surely not a time to sell! Regards, Tom

To: technetx who wrote (88)	7/9/1998 12:58:00 AM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

The Wall Street Journal - July 7, 1998 Small Caps Move Higher, But Trail Blue-Chip Market By THOMAS GRANAHAN Dow Jones Newswires Immucor received clearance from the U.S. Food and Drug Administration to market ABS 2000, a walk-away instrument for the hospital blood-bank transfusion laboratory, in the U.S. The stock moved up by 1 7/8, or 22%, to 10 3/8 on the news. This was the only printed mention regarding Immucor that I could find. Surely, business reporters could do much better in their coverage of this event. Only internet related companies appear to be receiving any in depth mention. Regards, Tom